These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3735107)

  • 1. Degradation pathway of pralidoxime chloride in concentrated acidic solution.
    Fyhr P; Brodin A; Ernerot L; Lindquist J
    J Pharm Sci; 1986 Jun; 75(6):608-11. PubMed ID: 3735107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pralidoxime chloride stability-indicating assay and analysis of solution samples stored at room temperature for ten years.
    Schroeder AC; DiGiovanni JH; Von Bredow J; Heiffer MH
    J Pharm Sci; 1989 Feb; 78(2):132-6. PubMed ID: 2715935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of pralidoxime chloride and its major decomposition products in injectable solutions.
    Prue DG; Johnson RN; Kho BT
    J Pharm Sci; 1983 Jul; 72(7):751-6. PubMed ID: 6886980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of formulations containing pralidoxime mesylate by liquid chromatography.
    Utley D
    J Chromatogr; 1987 Jun; 396():237-50. PubMed ID: 3624373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiometric investigation of the stability of palladium(II) complex of pralidoxime chloride in aqueous solution.
    Karljiković-Rajić K; Stanković B
    J Pharm Biomed Anal; 1990; 8(8-12):705-9. PubMed ID: 2100611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of pralidoxime chloride in pharmaceutical dosage forms by isotachophoresis.
    Bodiroga M; Agbaba D; Zivanov-Stakic D; Popovic R
    J Pharm Biomed Anal; 1994 Jan; 12(1):127-9. PubMed ID: 8161599
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of concentrated aqueous solutions of pralidoxime chloride.
    Ellin RI
    J Pharm Sci; 1982 Sep; 71(9):1057-9. PubMed ID: 7131276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the stability and decomposition of the Hagedorn-oxime HLö 7 in aqueous solution.
    Eyer P; Ladstetter B; Schäfer W; Sonnenbichler J
    Arch Toxicol; 1989; 63(1):59-67. PubMed ID: 2742503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of N-methyl-2-hydroxyimino-methyl pyridinium iodide (2-PAM) content in aqueous solutions].
    Cesk Farm; 1969 Oct; 18(8):417-8. PubMed ID: 5370688
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of atropine in the presence of pralidoxime chloride.
    Lindén E; Schill G
    Acta Pharm Suec; 1967 Dec; 4(6):327-34. PubMed ID: 5589691
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of aging of aqueous pralidoxime solutions on assay, toxicity, and antidotal activity.
    Lehman RA; Bloch LP
    J Pharm Sci; 1965 Jul; 54(7):1035-8. PubMed ID: 5862515
    [No Abstract]   [Full Text] [Related]  

  • 12. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aqueous stability of bupropion.
    O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
    J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a reverse phase liquid chromatography method for the simultaneous quantification of eserine and pralidoxime chloride in drugs-in-adhesive matrix type transdermal patches.
    Banerjee S; Chattopadhyay P; Ghosh A; Kaity S; Veer V
    Drug Res (Stuttg); 2013 Sep; 63(9):450-6. PubMed ID: 23633237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic study on the degradation of prazepam in acidic aqueous solutions by high-performance liquid chromatography and fourth-order derivative ultraviolet spectrophotometry.
    Archontaki HA; Panderi IE; Gikas EE; Parissi-Poulou M
    J Pharm Biomed Anal; 1998 Aug; 17(4-5):739-50. PubMed ID: 9682158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of a pyridinium derivative by reaction of 4-hydroxypentenal with glycine.
    Napetschnig S; Schauenstein E; Esterbauer H
    Chem Biol Interact; 1988; 68(3-4):165-77. PubMed ID: 2975196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved delivery through biological membranes. 1. Synthesis and properties of 1-methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride.
    Bodor N; Shek E; Higuchi T
    J Med Chem; 1976 Jan; 19(1):102-7. PubMed ID: 1246030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of three related bis(pyridinium)aldoximes in aqueous solutions at high concentrations: examples of unexpectedly rapid amide group hydrolysis.
    Korte WD; Shih ML
    J Pharm Sci; 1993 Aug; 82(8):782-6. PubMed ID: 8377113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion-exclusion chromatography of compounds of biological interest.
    Crone HD
    J Chromatogr; 1975 Apr; 107(1):25-33. PubMed ID: 237935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of pralidoxime mesylate on the measurement of cyanide concentrations in solutions.
    Ballantyne B
    Vet Hum Toxicol; 1984; 26 Suppl 2():23-7. PubMed ID: 6523723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.